a

1. LDR short interest up by 7.8% — 5 quick notes

Written by Anuja Vaidya | Tuesday, 03 March 2015 00:00
LDR reported a rise of 92,864 shares or 7.8 percent in the short interest, according to a report by Candle Strips Bar & Graph Report.
IlluminOss Medical announced that the first patient has been enrolled in its EU Light Fix trial for the treatment of humerus fractures due to metastatic carcinoma.
Vivex Biomedical named Lou Barnes president and COO of UMTB Biomedical.
LDR entered into a worldwide distribution agreement with Sentio to distribute the SentioMMG nerve mapping system.
The Federal Circuit overturned a previous court's decision in patent litigation between NuVasive and Medtronic.
InVivo Therapeutics' stock is heating up as the company begins to launch the Neuro-Spinal Scaffold trial at more sites across the United States, according to a Microcap Daily report.

7. 6 key notes on Mazor Robotics' short interest decline

Written by Laura Dyrda | Tuesday, 03 March 2015 00:00
Mazor Robotics experienced a large decline in short interest last month, according to a WKRB News & Analysis report.

8. Integra LifeSciences gets "buy" rating — 5 quick facts

Written by Laura Dyrda | Tuesday, 03 March 2015 00:00
Integra LifeSciences achieved a "buy" recommendation from a few different brokerages, according to a Mideast times report.
Integra LifeSciences reported a rise of 2.9 percent or 55,126 shares in its short interest, according to a report from Candle Strips Bar & Graph Report.
More than 15,000 procedures with SI-BONE's iFuse Implant System have been performed.
Alphatec Holdings, parent company of Alphatec Spine, reported a huge drop in short interest, according to a Candle Strips report.
WallachBeth Capital increased their price objective on shares of Globus Medical from $26 to $30, according to a Sleek Money report.

13. 5 key notes on K2M's stock rating — Now "Strong Buy"

Written by Laura Dyrda | Monday, 02 March 2015 00:00
K2M received a new rating score for stocks from four different Zacks brokers, according to a Mideast Times report.
Here are 22 key notes on spine and orthopedic device companies.
Brean Capital Equities research analysts increased their price objective on NuVasive shares from $53 to $55 in a research note, according to a Dakota Financial News report.
Alphatec Holdings, the parent company of Alphatec Spine, announced financial results for the fourth quarter and full year ended Dec. 31, 2014.

17. Spine device company stock report: 5 key companies — Feb. 26

Written by Laura Dyrda | Thursday, 26 February 2015 00:00
Here are the stock reports from five spine device companies for Feb. 26, 2015, including whether the numbers are up or down from last week.

18. Invibio Spine's PEEK-OPTIMA HA Enhanced shows promise

Written by Laura Dyrda | Thursday, 26 February 2015 00:00
Invibio Spine released a white paper about PEEK-OPTIMA HA Enhanced.
JMEA Corporation, an orthopedic medical device company, is one of the recipients of the 2015 Life Sciences Impact Grant Awards presented by The Montgomery County Department of Economic Development.
Globus Medical reported record profits for the fourth quarter and full year in 2014.
  • «
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  4 
  •  5 
  •  6 
  •  7 
  •  8 
  •  9 
  •  10 
  •  Next 
  • »
Page 1 of 195